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lowed. Serial CTA was performed in 59 controls, while 67
patients were followed with the NCT protocol. Mean
follow-up was 2.07 years. There were no differences in Age,
Gender, or Initial Aneurysm Volume or Size. There were
35 total Endoleaks identified. Twenty of these were early
(30days post EVAR) Endoleaks. The remaining 15 leaks
were late in nature, 10 in the contrast group and 5 in the
noncontrast group, p  0.17. NCT aneurysm sac volume
changes prompted contrasted studies in all 5 late leaks.
Mean volume change was 11.2 cm3, an average change of
5.88%. These findings were not significantly different than
the late leaks found by routine contrast studies, 8.9cm3
(4.98%, p  0.58). There were no delayed ruptures or
emergent reinterventions in the NCT group.
Conclusions: After EVAR, serial volumetric analysis
with noncontrast enhanced Computed Tomography ap-
pears to be a safe and effective follow-up imaging modality.
It requires the involvement of dedicated cardiovascular
radiologists. Further, long-term and larger investigation is
needed to confirm the safety and efficacy of this follow-up
protocol.
Author Disclosures: J. L. Bobadilla: Nothing to disclose;
M. Pozniak: Nothing to disclose; S. Reeder: Nothing to
disclose; P. Suwanabol: Nothing to disclose; G. Tefera:
Nothing to disclose.
PS30.
The Impact of Co-morbid Abdominal Aortic Aneu-
rysm on Outcomes After Coronary Artery Bypass
Grafting
Raja R. Gopaldas1, Danny Chu3, Faisal G. Bakaeen3, Tam
K. Dao4, Joseph Huh2, Scott A. LeMaire2, Joseph S.
Coselli1. 1Division of Cardiothoracic Surgery, Baylor Col-
lege of Medicine, Houston, TX; 2Texas Heart Institute at
St. Luke’s Episcopal Hospital, Houston, TX; 3Michael E.
DeBakey Veterans Affairs Medical Center, Houston, TX;
4Department of Education Psychology, University of
Houston, Houston, TX
Objectives: Unlike atherosclerotic peripheral vascular
disease, comorbid abdominal aortic aneurysm (AAA) has
not been studied in terms of its effects on outcomes after
coronary artery bypass grafting (CABG). We aimed to
determine whether having comorbid AAA affected the
in-hospital outcomes of patients who had undergone iso-
lated CABG surgery.
Methods: Using Nationwide Inpatient Sample data
from 1998-2007, we identified 2, 607, 522 patients who
underwent isolated CABG, of whom 32, 957 had comor-
bid AAA. Hierarchic multivariable regression models were
used to analyze the independent effect of AAA on out-
comes. Primary end points were in-hospital mortality and
morbidity. Secondary end points were hospital length of
stay and charges.Results: Patients who had concomitant AAA were
older (71 8 vs 65 11 years; p 0.001) and had higher
Deyo comorbidity scores (4.7  1.4 vs 3.0  1.7; p 
0.001) than patients without AAA. Unadjusted in-hospital
mortality was similar for both groups (2.4% for patients
with AAA vs 2.5% without AAA; p  0.27). After risk-
adjustment, AAA did not affect mortality (OR  1.0; p 
0.6). Patients with AAA had a 20% higher likelihood of
overall post-CABG morbidity (odds ratio [OR]  1.21;
p  0.001). The length of stay was slightly longer for
patients with AAA by 0.15 days (p  0.01), and hospital
charges were higher by $1291 (p  0.01). Subgroup anal-
ysis revealed that patients with AAA were more likely to
have cardiac (OR  1.2; p  0.001) and neurologic com-
plications (OR  1.2; p  0.005) after CABG.
Conclusions: AAA independently predicted higher
overall morbidity, specifically cardiac and neurologic
complications, in patients who underwent CABG. In-
hospital mortality was not affected, although in-hospital
length of stay and charges were higher in patients with
AAA. Because the presence of AAA appears to have an
important independent influence on postoperative
CABG outcomes, further studies are required to deter-
mine whether AAA should be incorporated into CABG
risk-assessment models.
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Objectives: Studies have documented a slight but sig-
nificant deterioration of renal function after endovascular
repair of AAA (EVAR). We investigated whether medica-
tion with statins may prevent perioperative renal deteriora-
tion.
Methods: In 127 patients receiving EVAR the med-
ication was reliably retrievable. Patients were divided
according to whether their medication included statins
( 3 months). Secondly, they were subdivided according
to their supra- or infra-renal endograft fixation. Serum
creatinine and creatinine clearance were determined pre-
operatively at six and twelve months. Patients with
known preexisting renal disease, with incorrect place-
ment of the stent-graft resulting in severe renal artery
stenosis, and with occlusion or renal parenchymal infarc-
tion were excluded from the study.
Results: Patients receiving an infrarenal fixation of
their graft had no change in the renal function, regardless
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suprarenal fixation not receiving statins, a deterioration in
renal function was observed in the early postoperative
period (SCr preop vs SCr Postop.: 1.02  0.2 vs 1.11 
0.28, p  .001 and Cr. Cl preop vs Cr. Cl postop.: 74.1 
21.4 vs 68.0 21.4, p .001), whereas patients on statins
experienced no change in renal function (SCr preop vs SCr
postop: 0.99  0.24 vs 1.02  0.20 n.s. and Cr. Cl preop
vs Cr. Clpostop.: 76.4  19.1 vs 74.28  20.50, n.s.).
During follow-up, a constant worsening of renal function
at six and twelve months in all patients was observed,
irrespective of the medication with statins.
Conclusions: The present study suggests a slight
immediate deterioration of the renal function using SR
fixation, and this could be prevented by the use of statins.
During follow-up, statins did not protect from further
renal deterioration. Broader studies are needed to con-
firm a definitive relation between statin use and renal
protection during the endovascular repair of AAA.
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Objectives: To determine if EVAR improves outcomes
for ruptured AAA (rAAA). EVAR has become first line
therapy for rAAA at our institution, after initiating a pro-
tocol to efficiently evaluate aneurysm anatomy and facilitate
operating room access. This includes dedicated on-call staff
and a fully stocked endosuite.
Methods: Charts were retrospectively reviewed from
December 2000 to November 2009 for repair of infrarenal
rAAA. Primary endpoints include in-hospital mortality and
long-term survival. Secondary endpoints, include acute
limb ischemia, length of stay (LOS), ventilator dependent
respiratory failure (VDRF) and renal failure. Statistics in-
clude t-test, chi-square, Kaplan Meier, and multivariate
logistic regression.
Results: Fifty-four patients underwent repair (15
EVAR, 45 Open). In-hospital mortality was 20% EVAR
and 51% open (p  0.01, odds ratio [OR] 8.6, 95%
confidence interval [CI], 1.7-42.8). Kaplan Meier analysis
shows improved long-term survival with EVAR (p  0.05,
log rank). Mean LOS ( 1 day) was 9.1 days for EVAR and
21.5 days for open repair (p  0.05). VDRF was 7% for
EVAR and 38% for open repair (p 0.05, OR 8.6 [95% CI
1.02-72.4]). EVAR utilization increased from 17% to 60%
over the study period.Conclusions:Endovascular repair of rAAA used within
a protocol to facilitate anatomic evaluation and operating
room access reduced both in-hospital mortality and long-
termmortality significantly, as well as perioperative compli-
cations and LOS.
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Objectives: To evaluate the short- and long-term out-
come of Fascial Closure Technique (FC) as a means of
closure of femoral artery access sites after EVAR.
Methods: 92 consecutive patients (163 femoral access
sites) between April 2007 and April 2008 were evaluated
retrospectively. 33 procedures (36%)were emergent. Pre- and
postoperative data were collected from computerizedmedical
records for analysis of demographics and the rate of compli-
cations (bleeding, infection, thrombosis, pseudoaneurysms,
stenosis). Pre- and one year postoperative CT measurements
were performed with regards to stenosis, presence of plaque,
subcutaneous fat layer, thrombosis and pseudoaneurysms.
